Your browser doesn't support javascript.
loading
Evaluation of biomarkers for monitoring thrombogenic potential of FXaI16L.
Bolt, Michael W; Hua, Fei; Brenneman, Karrie A; Graves, John E; Arkin, Steven; Criswell, Kay.
Affiliation
  • Bolt MW; Drug Safety Research and Development.
  • Hua F; Rare Disease Research Unit, Pfizer Inc, Cambridge, Massachusetts.
  • Brenneman KA; Drug Safety Research and Development.
  • Graves JE; Drug Safety Research and Development.
  • Arkin S; Rare Disease Research Unit, Pfizer Inc, Cambridge, Massachusetts.
  • Criswell K; Clinical Research Unit, Pfizer, Inc., Groton, Connecticut, USA.
Blood Coagul Fibrinolysis ; 31(1): 16-28, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31687988
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Blood Coagulation Tests / Biomarkers / Factor Xa / Anticoagulants Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2020 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Blood Coagulation Tests / Biomarkers / Factor Xa / Anticoagulants Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Coagul Fibrinolysis Journal subject: ANGIOLOGIA / HEMATOLOGIA Year: 2020 Document type: Article Country of publication: United kingdom